09:40 AM EST - WEX Pharmaceuticals Inc. : reported a net loss for the fiscal year 2009 of $8.05 million or $0.13 per share, compared to a net loss of $2.80 million or $0.05 per share for the fiscal year 2008. This increase in net loss of $5.25 million was due to, amongst other items, larger research and development expenditures of $1.98 million, increased interest expense on convertible debentures of $1.08 million, increase in loss from discontinued operations of $830,000 and the settlement gains from preceding year in the U.S. dollar denominated series 5.5% convertible debentures debt of $1.21 million. The loss was offset by a reduction in general and administrative expenses of $570,000. WEX Pharmaceuticals Inc.
shares T.WXI are trading even at $0.24.
